ESR1 and breast cancer: More specifically, ERα‐36 signaling, interacting with STAT3, has been shown to mediate the upregulation of MMP‐2 and MMP‐9 expression, leading to ECM remodeling and, consequently, facilitating breast cancer cell invasion and migration (Fig. 4) [29].